APEX HEALTHCARE BHD
KLSE (MYR): AHEALTH (7090)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
3.87
Today's Change
-0.06 (1.53%)
Day's Change
3.87 - 3.98
Trading Volume
272,900
Overview
Market Cap
1,853 Million
NOSH
479 Million
Avg Volume (4 weeks)
158,884
4 Weeks Range
3.87 - 4.18
4 Weeks Price Volatility (%)
0.00%
52 Weeks Range
2.65 - 4.18
52 Weeks Price Volatility (%)
79.74%
Previous Close
3.87
Open
3.94
Bid
3.86 x 5,400
Ask
3.87 x 900
Day's Range
3.87 - 3.98
Trading Volume
272,900
Financial Highlight
Latest Quarter | Ann. Date
31-Mar-2023 [#1] | 24-May-2023
Next QR | Est. Ann. Date
30-Jun-2023 | 16-Aug-2023
T4Q P/E | EY
16.92 | 5.91%
T4Q DY | Payout %
2.18% | 36.82%
T4Q NAPS | P/NAPS
1.22 | 3.18
T4Q NP Margin | ROE
12.06% | 18.77%
Market Buzz
2023-05-26
2023-05-25
2023-05-25
2023-05-24
News and Blogs
Company Profile
Sector: HEALTH CARE
Sector: HEALTH CARE
Subsector: PHARMACEUTICALS
Subsector: PHARMACEUTICALS
Description:
Apex Healthcare Bhd is a public limited liability company, incorporated and domiciled in Malaysia. The Company is an investment holding company for a group of companies engaged in the business of manufacturing, marketing, distributing and retailing of pharmaceuticals, diagnostics, orthopaedics and consumer healthcare products with direct operations in Malaysia, Singapore and Vietnam. Its operations are organized into three segments: Manufacturing and Marketing, Wholesale and Distribution, and Corporate.
Discussions
5 people like this. Showing 50 of 480 comments
Healthcare stocks will do well in high inflation environment, except glove companies with large CAPex
2022-07-12 22:09
no reason, don't simply spread fake news causing other people panic.
you definitely is a bad guy.
2022-09-01 15:42
Dr Kee buy also…..so you decide la. For me, I’m not selling. This stock will reward long term shareholder
2022-09-08 12:18
normal people need to try their luck
but why rich people can earn money so easily..?
2022-11-16 15:00
Apex Healthcare Berhad (KLSE:AHEALTH) Third Quarter 2022 Results
Key Financial Results
Revenue: RM232.1m (up 10.0% from 3Q 2021).
Net income: RM26.9m (up 92% from 3Q 2021).
Profit margin: 12% (up from 6.6% in 3Q 2021). The increase in margin was driven by higher revenue.
EPS: RM0.057 (up from RM0.03 in 3Q 2021).
2022-11-18 08:55
This is one of the best stock in klse.
You will be regretted if you miss this opportunity to buy in now @RM 3.40. 5 years later you will feel fortunate that you have made this right decision.
I topped up @ RM 3.40
Trust me.
2022-11-18 09:00
this one following in the footsteps of Kotra. Solid business even in recession times..
2022-12-20 11:11
Quality pharma stocks like Kotra and Apex are underrated. Slowly and quietly go up is good..
2022-12-21 09:25
You are just fighting against prop traders at this time. The perfect moment to buy Kotra Industries was 1 year ago December 2021
2022-12-21 09:27
Breaking news: China ban medicine and glove export due to high demand to avoid shortage!
2022-12-22 08:52
Great QR. Apex Healthcare should be in everyone’s portfolio now
2023-02-23 09:58
Public Bank hold rating. Which means this stock will pump up at least 20%. Still have meat on the table
2023-02-23 12:54
@wall, mind sharing with us why Public Bank suggest hold but still have meat available..
2023-02-23 13:08
The trend and behavior of AHealth for me resembles of Public Bank. Create value to shareholders in long term.
2023-02-24 14:50
wow, broke RM4 on uptrend. Too bad took profit a bit early 3.90. Apex stock has outperformed Kotra this year by a country mile..
2 months ago
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
Security LastPr PE DY% Divcts ROE ttm-marg
AHEALTH (Pharmaceuticals) 4.09 19.35 2.1 8.5 17.92 11.5
2 months ago
In the light of these results, the Board has proposed
an increased final single-tier dividend of 3.5 sen per
share as well as a special dividend of 2.0 sen per share
in respect of financial year ended 31st December 2022
for shareholders’ approval at the forthcoming Annual
General Meeting (‘AGM’) scheduled in May 2023. In all,
total dividends paid and payable by the Group in respect
of financial year 2022 is 8.5 sen per ordinary share,
amounting to 40.2% of Group profit after tax.
1 month ago
The Board is also proposing a 1 for 2 bonus issue of
new shares, without capitalization of retained earnings,
to reward shareholders for their continuous support
and loyalty. We trust the bonus issue will help improve
trading liquidity and enlarge our base of shareholders
1 month ago
2022 marks the 60th anniversary of the founding of the
Group in 1962. From a retail pharmacy in Melaka, AHB has
grown to a public company with a market capitalization
of RM 1.68 billion1
with operations and commercial
presence in 20 territories today. An initial investment in
1,000 shares at the time of AHB’s Initial Public Offering
(‘IPO’) in year 2000 would be approximately 9,375 shares
if held till today, after 4 bonus issues2
. At RM 1.50 per
share at IPO, the value of that investment would be RM
33,000 today, based on the closing share price of RM
3.52 on 31st December 2022. This is a compound annual
growth rate in value of 15.09% in each of the last 22
years and made possible through the support of every
stakeholder, foremost our people, our customers, and
our shareholders
1 month ago
if this growth can persist, buy Ahealth let them runn our investment.
At 15% compound interest is very good already
not need hassle to buy what stocks to invest
1 month ago
If you have choice, which way you would prefer:
1). Kill a goose and collect all the gold eggs one off worth around RM 350 million. If you put in FD @3.25%, you get RM 10 million interest.
2). You continue to rear the goose and collect aboutRM 30 million gold eggs every year with compound increment of around 10% additional eggs. You have the risk of goose being die off anytime though not possible in a foresable future
1 month ago
Healthcare is the only sector that will perform well alongside hard assets (gold/commodities) in an era of stagflation
3 weeks ago
Post a Comment
Featured Posts
[31 MAY] Dive into MACD Divergences: A Powerful Indicator for Profitable Trading
[07 JUN] Uncovering the future stars of the Asian market
Looking for REITs with high returns? Check this out!
[14 MAR-31 JUN] Invite friends to join MQ Trader for extra 1,000 MQ Coins!
Trending Events
Apps
Top Articles
1
M+ Online Research Articles
2
MQ Market Updates
3
Good Articles to Share
Experts issue warning as Social Security’s ‘day of reckoning’ inches closer
4
Good Articles to Share
At least 3 mln Tunisians face food insecurity threat: agency
5
Good Articles to Share
6
Good Articles to Share
7
Good Articles to Share
Tens of thousands in Serbia protest mass shootings, government policies
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
wallstreetrookie
Nepo, I think everyone knows already
2022-07-12 22:08